GDF-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR Program

被引:0
|
作者
Ferreira, J. P. [1 ]
Sumin, M. [2 ]
Masson, S. [3 ]
Zannad, F. [1 ]
机构
[1] Univ Lorraine, Nancy, France
[2] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[3] Roche Diagnost Int Ltd, Rotkreuz, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:292 / 292
页数:1
相关论文
共 50 条
  • [1] Growth differentiation factor-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program
    Ferreira, Joao Pedro
    Packer, Milton
    Butler, Javed
    Filippatos, Gerasimos
    Pocock, Stuart J.
    Januzzi, James L.
    Sattar, Naveed
    Maldonado, Sandra Gonzalez
    Panova-Noeva, Marina
    Sumin, Mikhail
    Masson, Serge
    Anker, Stefan D.
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (01) : 155 - 164
  • [2] The Prognostic Value of GDF-15 in Heart Failure Patients
    Zhao, X. Y.
    Yang, Y. J.
    Zhang, J.
    CARDIOLOGY, 2009, 114 : 75 - 75
  • [3] Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials
    Ferreira, Joao Pedro
    Butler, Javed
    Anker, Stefan D.
    Januzzi, James L.
    Panova-Noeva, Marina
    Reese-Petersen, Alexander L.
    Sattar, Naveed
    Schueler, Elke
    Pocock, Stuart J.
    Filippatos, Gerasimos
    Packer, Milton
    Sumin, Mikhail
    Zannad, Faiez
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (02) : 274 - 284
  • [4] The Role of GDF-15 in Heart Failure Patients With Chronic Kidney Disease
    Benes, Jan
    Kotrc, Martin
    Wohlfahrt, Peter
    Conrad, Michael J.
    Franekova, Janka
    Jabor, Antonin
    Lupinek, Petr
    Kautzner, Josef
    Melenovsky, Vojtech
    Jarolim, Petr
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (04) : 462 - 470
  • [5] Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced
    Ferreira, Joao Pedro
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Iwata, Tomoko
    Salsali, Afshin
    Zeller, Cordula
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (04) : 708 - 715
  • [6] Prognostic value of serial measurements of gdf-15 in acute heart failure
    Gurgoze, M. T.
    Baart, S. J.
    Kardys, I.
    Akkerhuis, K. M.
    Manintveld, O. C.
    Postmus, D.
    Hillege, H. L.
    Van Vark, L. C.
    Asselbergs, F. W.
    La-Rocca, H. P. Brunner
    Van den Bos, E. J.
    Pinto, Y. M.
    Boersma, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 184 - 185
  • [7] Growth Differentiation Factor 15 (GDF-15), a New Biomarker in Heart Failure Management
    Sawalha, Khalid
    Norgard, Nicholas B.
    Drees, Betty M.
    Lopez-Candales, Angel
    CURRENT HEART FAILURE REPORTS, 2023, 20 (04) : 287 - 299
  • [8] Growth Differentiation Factor 15 (GDF-15), a New Biomarker in Heart Failure Management
    Khalid Sawalha
    Nicholas B. Norgard
    Betty M. Drees
    Angel López-Candales
    Current Heart Failure Reports, 2023, 20 : 287 - 299
  • [9] Circulating mononuclear cells and plasma GDF-15 levels in heart failure patients
    Zhuo, Xiaozhen
    Gong, Ming
    Wu, Yue
    Wang, Xuehui
    Wang, Tingzhong
    Ma, Aiqun
    CARDIOLOGY, 2011, 120 : 22 - 22
  • [10] Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study
    Justin B. Echouffo-Tcheugui
    Natalie Daya
    Chiadi E. Ndumele
    Kunihiro Matsushita
    Ron C. Hoogeveen
    Christie M. Ballantyne
    Josef Coresh
    Amil M. Shah
    Elizabeth Selvin
    Diabetologia, 2022, 65 : 955 - 963